期刊文献+

益生菌在炎症性肠病中的应用 被引量:14

Role of probiotics in the management of inflammatory bowel disease
下载PDF
导出
摘要 炎症性肠病(IBD)是一种慢性复发性肠道炎症性疾病,益生菌是近10余年用于IBD治疗的新兴药物.一些动物实验证实益生菌可减轻实验性结肠炎;临床研究提示益生菌用于维持缓解可能有效,但结果均不一致.益生菌用于IBD治疗还有许多问题有待解决.本文就益生菌在IBD中应用的研究情况作一简要综述. Inflammatory bowel disease(IBD) is a disorder characterized by chronic recurrent colitis.Probiotics have emerged as a new therapy for IBD over the last decade.The eff icacy of probiotics in attenuating experimental colitis and preventing clinical relapse had been proved in some animal and human studies but data are still inconsistent.There are many problems to be solved in future studies.This review focuses on recent advances in understanding the role of probiotics in the management of IBD.
出处 《世界华人消化杂志》 CAS 北大核心 2010年第36期3891-3895,共5页 World Chinese Journal of Digestology
关键词 益生菌 炎症性肠病 实验性结肠炎 Probiotics Inflammatory bowel disease Experimental colitis
  • 相关文献

参考文献3

二级参考文献15

  • 1Morris GP,Beck PL,Herridge MS,et al.Hapten-induced model of chronic inflammation and ulceration in the rat colon.Gastroenterology,1989,96:795-803.
  • 2Llopis M,Antolin M,Guarner F,et al.Mucosal colonisation with Lactobacillus casei mitigates barrier injury induced by exposure to trinitronbenzene sulphonic acid.Gut,2005,54:955-959.
  • 3McCarthy J,O'Mahony L,O'Callaghan L,et al.Double blind,placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance.Gut,2003,52:975-980.
  • 4Caplan MS,Miller-Catchpole R,Kaup S,et al.Bifidobacterial supplementation reduces the incidence of necrotizing enterocolitis in a neonatal rat model.Gastroenterology,1999,117:577-583.
  • 5Kamada N,Inoue N,Hisamatsu T,et al.Nonpathogenic Escherichia coli strain Nissle 1917 prevents murine acute and chronic colitis.Inflamm Bowel Dis,2005,11:455-463.
  • 6Madsen KL,Doyle JS,Jewell LD,et al.Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice.Gastroenterology,1999,116:1107-1114.
  • 7Philippe D,Dubuquoy L,Groux H,et al.Anti inflammatory properties of the muopioid receptor support its use in the treat ment of colon inflammation.J Clin Invest,2003,111:1329-1338.
  • 8Sartor RB.Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases:antibiotics probiotics,and pre biotics.Gastroenterology,2004,126:1620-1633.
  • 9Ishikawa H,Akedo I,Umesaki Y,et al.Randomized controlled trial of the effect of bifidobacteria fermented milk on ulcerative colitis.J Am Coll Nutr,2003,22:56-63.
  • 10Malchow HA.Crohn's disease and Escherichia coli.A new ap proach in therapy to maintain remission of colonic Crohn's dis ease? J Clin Gastroenterol,1997,25:653-658.

共引文献93

同被引文献210

引证文献14

二级引证文献115

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部